University of Nottingham, Royal Derby Hospital Centre
Derby, DE22 3DT, United Kingdom
NCT Number: NCT07565935
Caloric restriction programmes are highly effective and safe interventions for inducing rapid weight loss and improvements in glycaemic control. The landmark DiRECT study showed that 68% of people completing a caloric restriction intervention achieved remission of type 2 diabetes (T2D) by one year. Consequently, the NHS Path to Remission (PTR) programme was developed to stimulate diabetes remission in individuals that meet certain criteria. Unfortunately, long-term follow-up of the DiRECT study suggests that in the majority of participants that achieved remission, diabetes relapses within 5 years. This necessitates a focus on identifying methods to improve long-term maintenance of diabetes remission.
High-intensity interval training (HIIT) involves several brief bursts of intense exercise, interspersed with recovery breaks, and is becoming increasingly popular. HIIT can cause improvements in cardiovascular fitness, reduce blood pressure, and lower body fat content in only a fraction of the time of traditional exercise methods. Specific to T2D, HIIT has been shown to improve pancreatic beta cell function, which is critically important for maintenance of long-term diabetes remission.
This pilot study is being conducted to determine whether participating in a home-based HIIT training programme may help maintain beta cell function in individuals that have achieved diabetes remission following the NHS PTR programme. The study will take place at the Royal Derby Hospital.
The intention is to recruit 20 participants from Derbyshire or Nottinghamshire that have achieved diabetes remission in the NHS PTR programme. Participants will be recruited following discharge from the programme and allocated to either perform a HIIT training programme (intervention group), or continue with usual care (control group) for 16 weeks.
Before starting, participants will attend the research department to have initial measurements taken including bioimpedance, fasting bloods, an intravenous glucose tolerance test, muscle ultrasound, electromyography and cardiopulmonary exercise testing. Following this, those in the intervention group will be asked to perform a home-based HIIT training programme 3 times per week and record details of each session in a booklet. The control group will be asked to continue with their habitual levels of physical activity. Participants will be contacted regularly to ensure their safety and compliance.
Trial opening soon.
Get Notified18 year–70 year
All sexes
Interventional
Not applicable
Derby, DE22 3DT, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High-intensity interval training
Time frame: Assessed at baseline and then follow-up (16 weeks)
Assessment of beta-cell function using insulin first phase response from an intravenous glucose tolerance test
Time frame: Assessed at baseline and then follow-up (16 weeks)
Measured during the intravenous glucose tolerance test (IVGTT) and calculated from fasting glucose and insulin using the homeostatic model of assessment for insulin resistance
Time frame: Assessed at baseline and then follow-up (16 weeks)
From measurement of glycated haemoglobin (HbA1c)
Time frame: Assessed at baseline and then follow-up (16 weeks)
Measurement of participant weight
Time frame: Assessed at baseline and then follow-up (16 weeks)
Measurement of fat mass and fat-free mass using bioimpedance analysis
Time frame: Assessed at baseline and then follow-up (16 weeks)
Assessed using muscle strength (1 repetition maximum) testing and electromyography
Time frame: Assessed at baseline and then follow-up (16 weeks)
Using muscle ultrasonography to assess muscle thickness, cross sectional area and fibre pennation angle
Time frame: Assessed at baseline and then follow-up (16 weeks)
Determined from be the highest rate of oxygen consumption obtained (VO2max) during a cardiopulmonary exercise test
Contact information is provided by the study sponsor or research team.
University of Nottingham
Other
Can High-Intensity Interval Training (HIIT) Reduce the Risk of Diabetes Relapse Following Discharge From the NHS Path to Remission Programme? - a Pilot Study
Acronym: HIITpostLCD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07556679
Body Weight, Diabetes Mellitus
Miami, Florida, United States
View Trial DetailsNCT07666581
Body Weight, Diabetes Mellitus
Bogotá, Cundinamarca, Colombia
View Trial DetailsNCT07575438
Body Weight, Diabetes Mellitus
Montreal, Quebec, Canada
View Trial DetailsNCT07539415
Body Weight, Diabetes Mellitus
Seoul, South Korea
View Trial Details